News | RIVM

Mpox vaccinations in 2022

More than 18 thousand people in the Netherlands have received one or more mpox vaccinations. The vaccination campaign was launched late last July, shortly after the outbreak began, and ended last month.

Science Photo Library / ANP

Vaccination campaign to end as number of monkeypox infections consistently low

The current monkeypox outbreak is virtually over, and therefore the vaccination campaign to stop the spread of monkeypox, or ‘apenpokken’ in Dutch, will soon be coming to an end.

Start of invitations for the seasonal flu vaccination

The invitation for the seasonal flu vaccination will land on your doormat this autumn. The flu vaccination protects people who are more likely to become ill or seriously ill from flu because of their age or medical condition.

One-third of target group now vaccinated against monkeypox

10,440 monkeypox vaccinations have already been administered in the Netherlands in the last few weeks. That represents about one-third of the target group currently eligible to get the vaccine against monkeypox.

Science Photo Library / ANP

Number of monkeypox infections continues to rise

More than 16,000 cases of monkeypox have now been confirmed worldwide, spread across 75 countries. Both the number of confirmed cases and the number of countries where the disease is present are continuing to rise

Monkeypox continues spreading

Over the past few weeks, 288 people in the Netherlands have tested positive for monkeypox. The number of new daily infections seems to be slowly increasing.

Science Photo Library / ANP

6 people in the Netherlands with monkeypox

There are now 6 cases of monkeypox in humans in the Netherlands.

Science Photo Library / ANP

First patient with monkeypox in the Netherlands

This afternoon, a patient with monkeypox was confirmed in the Netherlands for the first time. RIVM researchers confirmed that the person has monkeypox with a PCR test.

Science Photo Library / ANP

Guus Velders in Nature's "Ten people that mattered this year"

Researcher Dr Guus Velders of RIVM has made the Nature top-10 list of 2016. This means that, according to Nature, he was one of the 10 most influential scientists in 2016.

RIVM research basis for historic climate agreement on HFCs

Scientific research by RIVM’s Guus Velders stood partly at the basis of the HFC global climate agreement.